All Stories

  1. Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis
  2. Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8
  3. Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
  4. Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
  5. Effects of the autophagy modulators d-limonene and chloroquine on vimentin levels in SH-SY5Y cells
  6. Pain Assessment and Treatment in Dementia at the Time of Coronavirus Disease COVID-19
  7. Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation
  8. Modulation of Cerebral Store-operated Calcium Entry-regulatory Factor (SARAF) and Peripheral Orai1 Following Focal Cerebral Ischemia and Preconditioning in Mice
  9. Pharmacokinetic Interactions between Herbal Medicines and Drugs: Their Mechanisms and Clinical Relevance
  10. Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice
  11. Role of 5-HT1A Receptor in the Anxiolytic-Relaxant Effects of Bergamot Essential Oil in Rodent
  12. The Role of Autophagy in Glaucomatous Optic Neuropathy
  13. Pattern of triptans use: a retrospective prescription study in Calabria, Italy
  14. Brain networks reorganization and functional disability in glaucoma
  15. Effects of caloric restriction on retinal aging and neurodegeneration
  16. Evidence on the neuroprotective properties of brimonidine in glaucoma
  17. Impact of nutraceuticals on glaucoma: A systematic review
  18. Preface
  19. Azithromycin Affords Neuroprotection in Rat Undergone Transient Focal Cerebral Ischemia
  20. Aging Brain: In Search of Better Neurotherapeutics
  21. Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs
  22. Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats
  23. Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach
  24. New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
  25. The tricyclic antidepressant clomipramine inhibits neuronal autophagic flux
  26. Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy
  27. Eptinezumab for the treatment of migraine
  28. Possible involvement of the peripheral Mu-opioid system in antinociception induced by bergamot essential oil to allodynia after peripheral nerve injury
  29. Rapamycin and fasting sustain autophagy response activated by ischemia/reperfusion injury and promote retinal ganglion cell survival
  30. Antinociceptive effect of inhalation of the essential oil of bergamot in mice
  31. Glaucoma and Alzheimer Disease: One Age-Related Neurodegenerative Disease of the Brain
  32. Glaucoma: In Search of Better Neurotherapeutics
  33. Paradigm Shift to Neuroimmunomodulation for Translational Neuroprotection in Stroke
  34. On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases
  35. Neuroprotective agents in the management of glaucoma
  36. Early LC3 lipidation induced by d -limonene does not rely on mTOR inhibition, ERK activation and ROS production and it is associated with reduced clonogenic capacity of SH-SY5Y neuroblastoma cells
  37. Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy
  38. Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance
  39. Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats
  40. Opioids Resistance in Chronic Pain Management
  41. Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms
  42. The need for better access to pain treatment: learning from drug consumption trends in the USA
  43. Poly(ADP-ribose) polymerase is not involved in the neuroprotection exerted by azithromycin against ischemic stroke in mice
  44. Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
  45. New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
  46. Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration
  47. Involvement of spinal glutamate in nociceptive behavior induced by intrathecal administration of hemokinin-1 in mice
  48. Drug repurposing for immune modulation in acute ischemic stroke
  49. Azithromycin protects mice against ischemic stroke injury by promoting macrophage transition towards M2 phenotype
  50. Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke
  51. Aromatherapy
  52. Rational modulation of the innate immune system for neuroprotection in ischemic stroke
  53. Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system
  54. Natural compounds and retinal ganglion cell neuroprotection
  55. Autophagy dysregulation and the fate of retinal ganglion cells in glaucomatous optic neuropathy
  56. Drug repurposing and beyond: the fundamental role of pharmacology
  57. Effect of plantar subcutaneous administration of bergamot essential oil and linalool on formalin-induced nociceptive behavior in mice
  58. Exploitation of Cytotoxicity of Some Essential Oils for Translation in Cancer Therapy
  59. Preface: New Trends in Basic and Clinical Research of Glaucoma: A Neurodegenerative Disease of the Visual System Part A
  60. Preface: New Trends in Basic and Clinical Research of Glaucoma:A Neurodegenerative Disease of the Visual System Part B
  61. Spinal Autophagy is Differently Modulated in Distinct Mouse Models of Neuropathic Pain
  62. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia
  63. Role of D-Limonene in Autophagy Induced by Bergamot Essential Oil in SH-SY5Y Neuroblastoma Cells
  64. Early reperfusion injury is associated to MMP2 and IL-1β elevation in cortical neurons of rats subjected to middle cerebral artery occlusion
  65. Inflammation in stroke
  66. The Essential Oil of Bergamot Stimulates Reactive Oxygen Species Production in Human Polymorphonuclear Leukocytes
  67. Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells
  68. Impairment of Neuronal Glutamate Uptake and Modulation of the Glutamate Transporter GLT-1 Induced by Retinal Ischemia
  69. In search of new targets for retinal neuroprotection: is there a role for autophagy?
  70. Brain involvement in glaucoma: advanced neuroimaging for understanding and monitoring a new target for therapy
  71. Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation
  72. Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception
  73. The involvement of the spinal release of glutamate and nitric oxide in peripheral noxious stimulation-induced pain-related behaviors—Study in mouse spinal microdialysis
  74. Death in pain: peripheral nerve injury and spinal neurodegenerative mechanisms
  75. Understanding anomalous adaptation in chronic pain for successful development of disease modifying drugs
  76. Neuroprotection by leptin in a rat model of permanent cerebral ischemia: effects on STAT3 phosphorylation in discrete cells of the brain
  77. Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo
  78. IkappaB-alpha expression following transient focal cerebral ischemia is modulated by nitric oxide
  79. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine
  80. Autophagy impairment in a mouse model of neuropathic pain
  81. Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism
  82. Neuropharmacology of the essential oil of bergamot
  83. Identification of distinct cellular pools of interleukin-1β during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat
  84. Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat
  85. Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro
  86. Chapter 28 Identification of Novel Pharmacological Targets to Minimize Excitotoxic Retinal Damage
  87. Chapter 25 Oxidative Stress in Stroke Pathophysiology
  88. Chapter 27 Prevention of Glutamate Accumulation and Upregulation of Phospho‐Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat
  89. Chapter 17 (–)‐Linalool Attenuates Allodynia in Neuropathic Pain Induced by Spinal Nerve Ligation in C57/Bl6 Mice
  90. Preface
  91. Chapter 18 Intraplantar Injection Of Bergamot Essential Oil Into The Mouse Hindpaw
  92. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators
  93. Post-ischemic brain damage: in search of novel neurotherapeutics
  94. Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death
  95. Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockade
  96. Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo
  97. Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion
  98. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection
  99. 17β-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat
  100. Preface
  101. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
  102. Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17β-estradiol
  103. Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats
  104. Identification of Transglutaminase 3 Splicing Isoforms
  105. Extracellular signal-regulated kinase (ERK) and nitric oxide synthase mediate intrathecal morphine-induced nociceptive behavior
  106. The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: Implication of monoterpene hydrocarbons
  107. Neuroinflammation in neuronal degeneration and repair
  108. Early Upregulation of Matrix Metalloproteinases Following Reperfusion Triggers Neuroinflammatory Mediators in Brain Ischemia in Rat
  109. Evidence to Implicate Early Modulation of Interleukin‐1β Expression in the Neuroprotection Afforded by 17β‐Estradiol in Male Rats Undergone Transient Middle Cerebral Artery Occlusion
  110. Evidence Implicating Matrix Metalloproteinases in the Mechanism Underlying Accumulation of IL‐1β and Neuronal Apoptosis in the Neocortex of HIV/gp120‐Exposed Rats
  111. Neuroprotective Effect of Nitroglycerin in a Rodent Model of Ischemic Stroke: Evaluation of Bcl‐2 Expression
  112. Preface
  113. Retinal Damage Caused by High Intraocular Pressure–Induced Transient Ischemia is Prevented by Coenzyme Q10 in Rat
  114. Evidence that Nitric Oxide Is Involved in the Control of Electrocortical Arousal
  115. Outcomes of a pharmacoepidemiological survey on the antibiotic treatment of uncomplicated acute cystitis in community☆
  116. The crucial role of neuronal plasticity in pain and cell death
  117. 17β-Estradiol Protects SH-SY5Y Cells Against HIV-1 gp120-Induced Cell Death: Evidence for a Role of Estrogen Receptors
  118. Editorial
  119. 17β-Estradiol Reduces Neuronal Apoptosis Induced by HIV-1 gp120 in the Neocortex of Rat
  120. Neurochemical Evidence to Implicate Elevated Glutamate in the Mechanisms of High Intraocular Pressure (IOP)-induced Retinal Ganglion Cell Death in Rat
  121. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens
  122. Neuroprotection by the caspase-1 inhibitor Ac-YVAD-(acyloxy)mk in experimental neuroAIDS is independent from IL-1β generation
  123. Estradiol reduces cytochrome c translocation and minimizes hippocampal damage caused by transient global ischemia in rat
  124. Transglutaminase 5 is acetylated at the N-terminal end
  125. Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex
  126. p73-alpha is capable of inducing scotin and ER stress
  127. A Novel Recessive Connexin 31 (GJB3) Mutation in a Case of Erythrokeratodermia Variabilis
  128. Involvement of a Glutamatergic Mechanism in δ-Dendrotoxin-Induced Hippocampal Neuronal Cell Loss in the Rat
  129. Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in theneocortex of rat
  130. Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS
  131. Calabria: sun, sand, and cell death
  132. Excitotoxic Mechanisms of Apoptosis in the Mammalian Visual System Following Monocular Visual Deprivation
  133. Cholesterol-dependent modulation of the toxicity of HIV-1 coat protein gp120 in human neuroblastoma cells
  134. Abnormal Expression of Neuronal Nitric Oxide Synthase Triggers Limbic Seizures and Hippocampal Damage in Rat
  135. HIV-1 Coat Glycoprotein gp120 Induces Apoptosis in Rat Brain Neocortex by Deranging the Arachidonate Cascade in Favor of Prostanoids
  136. HIV-1 coat protein gp120 stimulates interleukin-1β secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death
  137. Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor
  138. Functional role of inducible nitric oxide synthase on mouse colonic motility
  139. Evidence that increases of mitochondrial immunoreactive IL-1β by HIV-1 gp120 implicatein situcleavage of pro-IL-1β in the neocortex of rat
  140. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity
  141. Apoptosis in the Dorsal Lateral Geniculate Nucleus after Monocular Deprivation Involves Glutamate Signaling, NO Production, and PARP Activation
  142. Effects of α-dendrotoxin and dendrotoxin K on extracellular excitatory amino acids and on electroencephalograph spectral power in the hippocampus of anaesthetised rats
  143. Apoptosis Induced by gp120 in the Neocortex of Rat Involves Enhanced Expression of Cyclooxygenase Type 2 and Is Prevented by NMDA Receptor Antagonists and by the 21-Aminosteroid U-74389G
  144. Systemic administration of cocaine, given alone or in combination with sensory stimuli, differentially affects l-arginine-nitric oxide metabolism in discrete regions of the brain of rat
  145. Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat
  146. Conference
  147. Paraquat: A Useful Tool for thein vivoStudy of Mechanisms of Neuronal Cell Death
  148. The HIV Envelope Protein gp120 in the Nervous System
  149. Intrahippocampal injection of paraquat produces apoptotic cell death which is prevented by the lazaroid U74389G, in rats
  150. HIV-1 gp120-Induced Apoptosis in the Rat Neocortex Involves Enhanced Expression of Cyclo-oxygenase Type 2 (COX-2)
  151. Systemic Administration of Nω-Nitro-l-Arginine Methyl Ester and Indomethacin Reduces the Elevation of Brain PGE2Content and Prevents Seizures and Hippocampal Damage Evoked by LiCl and Tacrine in Rat
  152. The effect of hydroxylation of linoleoyl amides on their cannabinomimetic properties
  153. Seizures and Hippocampal Damage Produced by Dendrotoxin-K in Rats Is Prevented by the 21-Aminosteroid U-74389G
  154. N-Methyl-d-aspartate (NMDA) and non-NMDA glutamate receptor antagonists protect from apoptosis induced in the lateral geniculate nucleus of rabbits exposed to the dark
  155. Conference
  156. The human immunodeficiency virus type 1 (HIV-1) glycoprotein gp120 reduces the expression of neuronal nitric oxide synthase in the hippocampus but not in the cerebral cortex and medial septal nucleus of rat
  157. Nω-nitro-L-arginine methyl ester prevents apoptosis induced in the lateral geniculate nucleus by light deprivation in adult rabbit
  158. N-methyl-d-aspartate and nonn-methyl-d-aspartate receptors mediate seizures and CA1 hippocampal damage induced by dendrotoxin-K in rats
  159. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat.
  160. Systemic administration of lithium chloride and tacrine but not kainic acid augments citrulline content of rat brain
  161. Possible modulation of auditory middle latency responses by nitric oxide in the inferior colliculus of anaesthetized rats
  162. HIV-1 gp120 Produces DNA Fragmentation in the Cerebral Cortex of Rat
  163. Lack of Involvement of Nitric Oxide in the Mechanisms of Seizures and Hippocampal Damage Produced by Kainate and Ouabain in Rats
  164. Does the HIV-1 coat protein gp120 produce brain damage?
  165. Intracerebral injection of human immunodeficiency virus type 1 coat glycoprotein GP120 does not produce neurodegeneration in rats
  166. Neurodegeneration Produced by Intrahippocampal Injection of Paraquat is Reduced by Systemic Administration of the 21-Aminosteroid U74389F in Rats
  167. Hippocampal damage produced in rats by α-dendrotoxin—a selective K+ channel blocker—involves non-NMDA receptor activation
  168. Tetanus toxin as a neurobiological tool to study mechanisms of neuronal cell death in the mammalian brain
  169. Lithium and Tacrine Increase the Expression of Nitric Oxide Synthase mRNA in the Hippocampus of Rat
  170. Persistent muscarinic excitation in guinea-pig olfactory cortex neurons: Involvement of a slow post-stimulus afterdepolarizing current
  171. HIV gp120 Glycoprotein Stimulates the Inducible Isoform of NO Synthase in Human Cultured Astrocytoma Cells
  172. Systemic administration of lithium chloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats
  173. Inhibition by Nω-nitro-L-arginine methyl ester of the electrocortical arousal response in rats
  174. Antagonists of N-methyl-D-aspartate receptors block seizures induced by putrescine in the deep prepiriform cortex
  175. Altered Sensitivity of ?2-Adrenoceptors in the Brain during Aging in Rats
  176. Glutamate transmission is involved in the mechanisms of neuronal degeneration produced by intrahippocampal tetanus toxin in rats
  177. Production of Limbic Motor Seizures and Brain Damage by Systemic and Intracerebral Injections of Paraquat in Rats
  178. Neurotoxic Effects Induced by Intracerebral and Systemic Injection of Paraquat in Rats
  179. Production of seizures and brain damage in rats by α-dendrotoxin, a selective K+ channel blocker
  180. Tacrine-induced seizures and brain damage in LiCl-treated rats can be prevented by Nω-nitro-L-arginine methyl ester
  181. Epileptogenic effects of skin extracts from the Australian frog Pseudophryne coriacea after intracerebral microinfusion in rats
  182. Muscarinic receptor activation induces a prolonged post-stimulus afterdepolarization with a conductance decrease in guinea-pig olfactory cortex neurones in vitro
  183. High vulnerability of dentate granule cells to the neuropathological effects induced by intrahippocampal injection of tetanus toxin
  184. Muscarinic inhibition of excitatory neurotransmission in guinea-pig olfactory cortex slices: Weak antagonism by M3-muscarinic receptor antagonists
  185. Hippocampal damage produced by tetanus toxin in rats can be prevented by lesioning CA1 pyramidal cell excitatory afferents
  186. Characteristics of tetanus toxin and its exploitation in neurodegenerative studies
  187. Prevention by the NMDA receptor antagonist, MK801 of neuronal loss produced by tetanus toxin in the rat hippocampus
  188. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats
  189. Carbachol-induced suppression of the surface N-wave in guinea-pig olfactory cortex slices: Weak antagonism by M3-selective muscarinic antagonists, HHSiD and p-F-HHSiD
  190. Behavioural and neuropathological effects produced by tetanus toxin injected into the hippocampus of rats
  191. Muscarinic suppression of the evoked N-wave by oxotremorine-M-recorded in the guinea-pig olfactory cortex slice
  192. Tetanus toxin produces neuronal loss and a reduction in GABAA but not GABAB binding sites in rat hippocampus
  193. Age-dependent ECoG spectrum power alterations are reduced by phosphatidylserine in rats
  194. Inhibition by pertussis toxin of the soporific effects induced by stimulation of dopamine D2, autoreceptors in the ventral tegmental area in rats
  195. Effects of pertussis toxin on the behavioural and ECoG spectrum changes induced by clonidine and yohimbine after their microinfusion into the locus coeruleus
  196. Microinfusion of clonidine and yohimbine into locus coeruleus alters EEG power spectrum: effects of aging and reversal by phosphatidylserine
  197. Dopamine D-2 receptors in the ventral tegmental area mediate behavioural and electrocortical sleep of dopaminergic drugs in rats
  198. Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats
  199. Behavioural and ECoG spectrum power effects after intraventricular injection of drugs altering dopaminergic transmission in rats
  200. Behavioural and electrocortical changes induced by muscimol in rats withdrawn from chronic treatment with diazepam
  201. Behavioural and electrocortical spectrum power effects of growth hormone releasing factor in rats
  202. Electrocortical spectrum power effects of different classes of neuroleptics in rats
  203. Behavioural and spectrum power effects of opioid peptides in chicks
  204. Behavioural and Electrocortical Spectrum Power Changes After Intraventricular Injection of Patulin in Rats
  205. Evidence that behavioural and electrocortical sleep induced by guanfacine is due to stimulation of α2-adrenoceptors